Skip to menu Skip to content Skip to footer
Professor

Danny Liew

Email: 
Phone: 
+61 7 336 57487

Overview

Availability

Professor Danny Liew is:
Available for supervision

Works

Search Professor Danny Liew’s works on UQ eSpace

336 works between 2001 and 2026

21 - 40 of 336 works

2025

Conference Publication

LDL-C Target Attainment and Statin Use in Patients With ASCVD, Familial Hypercholesterolaemia, and Those Otherwise at Moderate/High-Risk of ASCVD in Australian General Practice (SCOPE-GP)

Watts, G.F., Audehm, R., Hespe, C., Liew, D., Berry, P., Chin, K.L., Rahman, M., Santani, R., Sciascia, C. and Tonkin, A. (2025). LDL-C Target Attainment and Statin Use in Patients With ASCVD, Familial Hypercholesterolaemia, and Those Otherwise at Moderate/High-Risk of ASCVD in Australian General Practice (SCOPE-GP). 73rd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Sydney, NSW Australia, 14-17 August 2025. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2025.06.882

LDL-C Target Attainment and Statin Use in Patients With ASCVD, Familial Hypercholesterolaemia, and Those Otherwise at Moderate/High-Risk of ASCVD in Australian General Practice (SCOPE-GP)

2025

Journal Article

Discontinuation of lipid-modifying agents and failure to achieve target LDL cholesterol levels across cardiovascular risk groups

Orman, Zhomart, Koh, Jia Wei, Trin, Caroline, Ademi, Zanfina, Zomer, Ella, Green, Sally, Berkovic, Danielle, Ilomaki, Jenni, Bell, Simon, Liew, Danny, Reid, Christopher M, Lybrand, Sean, Schoeninger, Brittany and Talic, Stella (2025). Discontinuation of lipid-modifying agents and failure to achieve target LDL cholesterol levels across cardiovascular risk groups. Journal of Clinical Lipidology, 19 (4), 835-843. doi: 10.1016/j.jacl.2025.06.010

Discontinuation of lipid-modifying agents and failure to achieve target LDL cholesterol levels across cardiovascular risk groups

2025

Journal Article

Dual antiplatelet therapy prior to percutaneous coronary intervention for acute coronary syndrome: prevalence and outcomes in contemporary practice

Goh, Shi Hui, Batchelor, Riley, Dinh, Diem, Brennan, Angela, Peters, Stacey, Stub, Dion, Reid, Christopher, Chan, William, Liew, Danny, Wilson, William, Lefkovits, Jeffrey and VCOR investigators (2025). Dual antiplatelet therapy prior to percutaneous coronary intervention for acute coronary syndrome: prevalence and outcomes in contemporary practice. Catheterization and Cardiovascular Interventions, 106 (1), 165-173. doi: 10.1002/ccd.31520

Dual antiplatelet therapy prior to percutaneous coronary intervention for acute coronary syndrome: prevalence and outcomes in contemporary practice

2025

Journal Article

Overall medicine burden for people on lipid-lowering therapy: cross-sectional analysis of national pharmacy dispensing data

Dunbar, Sally, Liew, Danny, Ilomaki, Jenni and Talic, Stella (2025). Overall medicine burden for people on lipid-lowering therapy: cross-sectional analysis of national pharmacy dispensing data. Australian Journal of General Practice, 54 (4), 222-228. doi: 10.31128/AJGP-02-24-7168

Overall medicine burden for people on lipid-lowering therapy: cross-sectional analysis of national pharmacy dispensing data

2025

Journal Article

A narrative review of the evidence for transcatheter aortic valve implants

Lee, Leonard, Chan, Brendan Min-Wei, Spencer, Melinda, Leung, Jovi, Liew, Danny and Kim, Hansoo (2025). A narrative review of the evidence for transcatheter aortic valve implants. Journal of Cardiovascular Development and Disease, 12 (4) 113, 1-12. doi: 10.3390/jcdd12040113

A narrative review of the evidence for transcatheter aortic valve implants

2025

Journal Article

Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis

Morton, Jedidiah I., Liew, Danny, Watts, Gerald F., Zoungas, Sophia, Nicholls, Stephen J., Reid, Christopher M. and Ademi, Zanfina (2025). Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis. PharmacoEconomics, 43 (3) e1001779, 331-349. doi: 10.1007/s40273-024-01454-z

Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis

2025

Journal Article

Unraveling the Future Productivity Burden of Cardiovascular Disease in Qatar: Investigating the Modifiable Risk Factors Control in Type 2 Diabetes

Abushanab, Dina, Al-Badriyeh, Daoud, Liew, Danny and Ademi, Zanfina (2025). Unraveling the Future Productivity Burden of Cardiovascular Disease in Qatar: Investigating the Modifiable Risk Factors Control in Type 2 Diabetes. American Journal of Preventive Cardiology, 22 100961, 1-9. doi: 10.1016/j.ajpc.2025.100961

Unraveling the Future Productivity Burden of Cardiovascular Disease in Qatar: Investigating the Modifiable Risk Factors Control in Type 2 Diabetes

2024

Journal Article

Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis

Inglis, Joshua M., Caughey, Gillian, Thynne, Tilenka, Brotherton, Kate, Liew, Danny, Mangoni, Arduino A. and Shakib, Sepehr (2024). Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis. BMC Geriatrics, 24 (1) 718, 1-18. doi: 10.1186/s12877-024-05297-3

Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis

2024

Journal Article

A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular Disease

Morton, Jedidiah I., Liew, Danny and Ademi, Zanfina (2024). A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular Disease. Value in Health, 27 (12), 1743-1752. doi: 10.1016/j.jval.2024.07.010

A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular Disease

2024

Journal Article

Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial

Choy, Matthew C., Li Wai Suen, Christopher F. D., Con, Danny, Boyd, Kristy, Pena, Raquel, Burrell, Kathryn, Rosella, Ourania, Proud, David, Brouwer, Richard, Gorelik, Alexandra, Liew, Danny, Connell, William R., Wright, Emily K., Taylor, Kirstin M., Pudipeddi, Aviv, Sawers, Michelle, Christensen, Britt, Ng, Watson, Begun, Jakob, Radford-Smith, Graham, Garg, Mayur, Martin, Neal, van Langenberg, Daniel R., Ding, Nik S., Beswick, Lauren, Leong, Rupert W., Sparrow, Miles P. and De Cruz, Peter (2024). Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology & Hepatology, 9 (11), 981-996. doi: 10.1016/s2468-1253(24)00200-0

Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial

2024

Journal Article

A non randomised pilot study to investigate the acceptability and feasibility of LivR Well: a multifaceted 28-day home based liver optimisation program for acute-on-chronic liver failure

Ngu, Natalie L. Y., Saxby, Edward, Worland, Thomas, Anderson, Patricia, Stothers, Lisa, Hunter, Jo, Elford, Alexander T., Ha, Phil, Hartley, Imogen, Roberts, Andrew, Seah, Dean, Tambakis, George, Connoley, Declan, Figredo, Anita, Ratnam, Dilip, Liew, Danny, Rogers, Benjamin, Sievert, William, Bell, Sally and Le, Suong (2024). A non randomised pilot study to investigate the acceptability and feasibility of LivR Well: a multifaceted 28-day home based liver optimisation program for acute-on-chronic liver failure. Gastro Hep Advances, 4 (2) 100567, 1-10. doi: 10.1016/j.gastha.2024.10.007

A non randomised pilot study to investigate the acceptability and feasibility of LivR Well: a multifaceted 28-day home based liver optimisation program for acute-on-chronic liver failure

2024

Journal Article

Association of Drug–Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis

Inglis, Joshua M., Caughey, Gillian, Thynne, Tilenka, Brotherton, Kate, Liew, Danny, Mangoni, Arduino A. and Shakib, Sepehr (2024). Association of Drug–Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Drugs - Real World Outcomes, 11 (3), 345-360. doi: 10.1007/s40801-024-00432-3

Association of Drug–Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis

2024

Journal Article

Prevalence and Predictors of Emergency Medical Service Use in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Baradi, Arul, Dinh, Diem T., Brennan, Angela, Stub, Dion, Somaratne, Jithendra, Palmer, Sonny, Nehme, Ziad, Andrew, Emily, Smith, Karen, Liew, Danny, Reid, Christopher M., Lefkovits, Jeffrey and Wilson, Andrew (2024). Prevalence and Predictors of Emergency Medical Service Use in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. Heart Lung and Circulation, 33 (7), 990-997. doi: 10.1016/j.hlc.2024.02.011

Prevalence and Predictors of Emergency Medical Service Use in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

2024

Journal Article

SGLT2 inhibitor-associated ketoacidosis vs Type 1 diabetes-associated ketoacidosis

Umapathysivam, Mahesh M., Morgan, Bethany, Inglis, Joshua M., Meyer, Emily, Liew, Danny, Thiruvenkatarajan, Venkatesan and Jesudason, David (2024). SGLT2 inhibitor-associated ketoacidosis vs Type 1 diabetes-associated ketoacidosis. JAMA Network Open, 7 (3) e242744. doi: 10.1001/jamanetworkopen.2024.2744

SGLT2 inhibitor-associated ketoacidosis vs Type 1 diabetes-associated ketoacidosis

2024

Conference Publication

Digital health for myocardial infarction: research topics and trends

Pelly, Melissa, Fatehi, Farhad, Samadbeik, Mahnaz, Liew, Danny and Verdejo-Garcia, Antonio (2024). Digital health for myocardial infarction: research topics and trends. 19th World Congress on Medical and Health Informatics, Sydney, NSW, Australia, 8 - 12 July 2023. Amsterdam, Netherlands: IOS Press. doi: 10.3233/shti231001

Digital health for myocardial infarction: research topics and trends

2024

Journal Article

Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10-year forecasting model

Abushanab, Dina, Al-Badriyeh, Daoud, Marquina, Clara, Liew, Danny, Al-Zaidan, Manal, Ghaith Al-Kuwari, Mohammed, Abdulmajeed, Jazeel and Ademi, Zanfina (2024). Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10-year forecasting model. Diabetes, Obesity and Metabolism, 26 (1), 148-159. doi: 10.1111/dom.15299

Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10-year forecasting model

2024

Journal Article

Lipid-lowering strategies for primary prevention of coronary heart disease in the UK: a cost-effectiveness analysis

Morton, Jedidiah I., Marquina, Clara, Lloyd, Melanie, Watts, Gerald F., Zoungas, Sophia, Liew, Danny and Ademi, Zanfina (2024). Lipid-lowering strategies for primary prevention of coronary heart disease in the UK: a cost-effectiveness analysis. PharmacoEconomics, 42 (1), 91-107. doi: 10.1007/s40273-023-01306-2

Lipid-lowering strategies for primary prevention of coronary heart disease in the UK: a cost-effectiveness analysis

2023

Journal Article

Digital health secondary prevention using co-design procedures: focus group study with health care providers and patients with myocardial infarction

Pelly, Melissa Louise, Fatehi, Farhad, Liew, Danny and Verdejo-Garcia, Antonio (2023). Digital health secondary prevention using co-design procedures: focus group study with health care providers and patients with myocardial infarction. JMIR Cardio, 7 e49892, e49892-7. doi: 10.2196/49892

Digital health secondary prevention using co-design procedures: focus group study with health care providers and patients with myocardial infarction

2023

Journal Article

The Adelaide Score: an artificial intelligence measure of readiness for discharge after general surgery

Kovoor, Joshua G., Bacchi, Stephen, Gupta, Aashray K., Stretton, Brandon, Malycha, James, Reddi, Benjamin A., Liew, Danny, O'Callaghan, Patrick G., Beltrame, John F., Zannettino, Andrew C., Jones, Karen L., Horowitz, Michael, Dobbins, Christopher, Hewett, Peter J., Trochsler, Markus I. and Maddern, Guy J. (2023). The Adelaide Score: an artificial intelligence measure of readiness for discharge after general surgery. ANZ Journal of Surgery, 93 (9), 2119-2124. doi: 10.1111/ans.18546

The Adelaide Score: an artificial intelligence measure of readiness for discharge after general surgery

2023

Journal Article

A systematic review of cost-effectiveness of non-statin lipid-lowering drugs for primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus

Abushanab, Dina, Al-Badriyeh, Daoud, Marquina, Clara, Bailey, Cate, Jaam, Myriam, Liew, Danny and Ademi, Zanfina (2023). A systematic review of cost-effectiveness of non-statin lipid-lowering drugs for primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. Current Problems in Cardiology, 48 (8) 101211, 1-36. doi: 10.1016/j.cpcardiol.2022.101211

A systematic review of cost-effectiveness of non-statin lipid-lowering drugs for primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus

Funding

Current funding

  • 2025 - 2026
    A novel approach integrating genomics into the health economic modelling of therapeutics (NHMRC Ideas grant administered by Monash University)
    Monash University
    Open grant
  • 2025 - 2027
    Health Translation Queensland
    2025-26 Supporting Research Translation Centres
    Open grant

Supervision

Availability

Professor Danny Liew is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Professor Danny Liew's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au